Pharmaceutical industry, non-communicable diseases and partnerships: More questions than answers
- PMID: 28959435
- PMCID: PMC5804034
- DOI: 10.7189/jogh.07.020301
Pharmaceutical industry, non-communicable diseases and partnerships: More questions than answers
Conflict of interest statement
Competing interests: The authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author). DB, ME and HH have past and ongoing collaborations with Boston University which will be responsible for monitoring the outcomes of this project. HH reports personal fees from WHO, Health Action International, and Access to Medicine Index 2016, outside the submitted work.
Similar articles
-
Time to align: development cooperation for the prevention and control of non-communicable diseases.BMJ. 2019 Jul 31;366:l4499. doi: 10.1136/bmj.l4499. BMJ. 2019. PMID: 31366599 Free PMC article.
-
New Partnerships to Advance Global Health Research for NCD.Glob Heart. 2016 Dec;11(4):473-478. doi: 10.1016/j.gheart.2016.10.022. Glob Heart. 2016. PMID: 27938846 No abstract available.
-
Synergies between Communicable and Noncommunicable Disease Programs to Enhance Global Health Security.Emerg Infect Dis. 2017 Dec;23(13):S40-6. doi: 10.3201/eid2313.170581. Emerg Infect Dis. 2017. PMID: 29155655 Free PMC article.
-
Globalization in the pharmaceutical industry, Part I.Int J Health Serv. 1998;28(1):67-105. doi: 10.2190/7JDR-2TFN-2B3X-TYF5. Int J Health Serv. 1998. PMID: 9493754 Review.
-
Contribution of the North Karelia Project to International Work in CVD and NCD Prevention and Health Promotion.Glob Heart. 2016 Jun;11(2):243-6. doi: 10.1016/j.gheart.2016.04.009. Glob Heart. 2016. PMID: 27242094 Review.
Cited by
-
The process of building the priority of neglected tropical diseases: A global policy analysis.PLoS Negl Trop Dis. 2020 Aug 12;14(8):e0008498. doi: 10.1371/journal.pntd.0008498. eCollection 2020 Aug. PLoS Negl Trop Dis. 2020. PMID: 32785262 Free PMC article.
-
Evaluation of pharmaceutical industry-led access programmes: a standardised framework.BMJ Glob Health. 2019 Aug 2;4(4):e001659. doi: 10.1136/bmjgh-2019-001659. eCollection 2019. BMJ Glob Health. 2019. PMID: 31423348 Free PMC article. Review.
-
The process of prioritization of non-communicable diseases in the global health policy arena.Health Policy Plan. 2019 Jun 1;34(5):370-383. doi: 10.1093/heapol/czz043. Health Policy Plan. 2019. PMID: 31199439 Free PMC article.
-
A global perspective on the issue of access to insulin.Diabetologia. 2021 May;64(5):954-962. doi: 10.1007/s00125-020-05375-2. Epub 2021 Jan 23. Diabetologia. 2021. PMID: 33483763 Free PMC article. Review.
References
-
- Access Accelerated. Biopharma companies partner and launch first-of-its-kind Global Initiative to address rise of Non-Communicable Diseases. 2017. Available: http://www.accessaccelerated.org/biopharma-companies-partner-and-launch-.... Accessed: 27 January 2017.
-
- UN. Goal 17: Revitalize the global partnership for sustainable development. 2016. Available: http://www.un.org/sustainabledevelopment/globalpartnerships/. Accessed: 27 January 2017.
-
- UICC. Our Partners. 2016. Available: http://www.uicc.org/partners/our-partners. Accessed: 26 January 2017.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical